Physician Assistant · Odessa, TX
NPI
1750808341
Since 2017
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
4040 Medical Park Dr
Odessa, TX, 79765
Phone (432) 333-6603
Groups this clinician bills Medicare through
Medicare paid, 2024
$125K
4,263 services
Medicare patients, 2024
839
Average age 74
Drug cost, 2024
$1.6M
1,620 prescriptions
Company payments, 2025
$5,156
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nathan Rosso was code 17003 (destruction skin lesion), 1,365 times for 254 patients. In total Nathan Rosso billed 4,263 services in 36 codes, and Medicare paid $125K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 1,365 | 254 | $3.83 | $5,231 |
| 99213 Office E&M - Established | Office | 617 | 524 | $42.99 | $27K |
| 17000 Destruction Skin Lesion | Office | 431 | 356 | $26.43 | $11K |
| 99214 Office E&M - Established | Office | 352 | 295 | $70.59 | $25K |
| 17110 Destruction Skin Lesion | Office | 327 | 297 | $57.91 | $19K |
| 11102 Skin Biopsy | Office | 306 | 274 | $46.66 | $14K |
| 11103 Skin Biopsy | Office | 200 | 97 | $30.78 | $6,157 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 133 | 29 | $0.50 | $66.56 |
| 99203 Office E&M - New | Office | 75 | 75 | $40.13 | $3,009 |
| 99204 Office E&M - New | Office | 47 | 47 | $100.81 | $4,738 |
| 96372 Injection Administration | Office | 26 | 21 | $6.21 | $161 |
| 17004 Destruction Skin Lesion | Office | 22 | 19 | $95.81 | $2,108 |
| 69100 Other Organ Systems | Office | 22 | 20 | $31.13 | $685 |
| 99212 Office E&M - Established | Office | 20 | 19 | $23.65 | $473 |
| 17111 Destruction Skin Lesion | Office | 13 | 12 | $73.95 | $961 |
By year: 2022 $113K for 2,886 services; 2023 $88K for 2,529 services; 2024 $125K for 4,263 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nathan Rosso prescribed most often to Medicare patients was Clobetasol Propionate, with 267 prescriptions and refills. In total Nathan Rosso wrote 1,620 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clobetasol Propionate Generic | 267 | 298 | 155 | $10K |
| Ketoconazole Generic | 192 | 214 | 91 | $3,347 |
| Triamcinolone Acetonide Generic | 99 | 109 | 55 | $1,567 |
| Minoxidil Generic | 97 | 170 | 28 | $318 |
| Mupirocin Generic | 75 | 75 | 53 | $479 |
| Doxycycline Hyclate Generic | 66 | 88 | 47 | $1,400 |
| Taltz Autoinjector Ixekizumab | 58 | 60 | Under 11 | $402K |
| Fluocinonide Generic | 52 | 56 | 41 | $2,536 |
| Mometasone Furoate Generic | 48 | 51 | 39 | $818 |
| Clindamycin Phosphate Generic | 46 | 46 | 20 | $2,823 |
| Dupixent Pen Dupilumab | 46 | 46 | Under 11 | $164K |
| Hydrocortisone Generic | 38 | 40 | 22 | $350 |
| Hydroxyzine Hcl Generic | 37 | 43 | 11 | $124 |
| Taltz Syringe Ixekizumab | 29 | 36 | Under 11 | $259K |
| Metronidazole Generic | 28 | 28 | 12 | $1,839 |
Brand drugs: 224 claims; generic drugs: 1,396 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nathan Rosso $5,156 ($5,156 in general payments such as food, travel and fees) from 19 companies. The largest payer was Abbvie Inc. with $751.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 35 | $751 |
| UCB, Inc. UCB.BR | 23 | $729 |
| Janssen Biotech, Inc. JNJ | 27 | $633 |
| Arcutis Biotherapeutics, Inc. ARQT | 27 | $550 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 17 | $488 |
| Novartis Pharmaceuticals Corporation NVS | 19 | $318 |
| Regeneron Healthcare Solutions, Inc. REGN | 12 | $309 |
| Lilly USA, LLC LLY | 12 | $254 |
| E.R. Squibb & Sons, L.L.C. BMY | 10 | $197 |
| Galderma Laboratories, L.P. GALD.SW | 13 | $178 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.